Siga Technologies INC Deferred Income Tax Assets, Net
Siga Technologies INC (SIGA) had Deferred Income Tax Assets, Net of $2.79 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $2.79M.
- 2026-03-31: Deferred Income Tax Assets, Net $5.09M.
- 2025-12-31: Deferred Income Tax Assets, Net $4.43M.
- 2025-09-30: Deferred Income Tax Assets, Net $1.56M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $2.79M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.43M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.56M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.97M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $11.13M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.85M 10-K · filed 2026-03-10 |
| 2024-09-30 | $12.10M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $11.61M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $11.01M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $11.05M 10-K · filed 2025-03-11 |
| 2023-09-30 | $7.90M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $7.59M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.73M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $6.25M 10-K · filed 2024-03-12 |
| 2022-09-30 | $4.18M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.04M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.42M 10-K · filed 2023-03-02 |
| 2021-09-30 | $2.95M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.73M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.57M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.54M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |